{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:49:33Z","timestamp":1791996573995,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T00:00:00Z","timestamp":1679788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T00:00:00Z","timestamp":1679788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01035-y","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T11:02:20Z","timestamp":1679828540000},"page":"3895-3905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta\u2011analysis"],"prefix":"10.1007","volume":"23","author":[{"given":"Junyan","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3870-417X","authenticated-orcid":false,"given":"Liwei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,26]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2013An update. Cancer Epidemiol Biomarkers Prev. 2016;25:16\u201327.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"1035_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin."},{"key":"1035_CR3","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fimmu.2020.02023","volume":"11","author":"Y Xu","year":"2020","unstructured":"Xu Y, Fu Y, Zhu B, Wang J, Zhang B. Predictive biomarkers of immune checkpoint inhibitors-related toxicities. Front Immunol. 2020;11:2023.","journal-title":"Front Immunol."},{"key":"1035_CR4","doi-asserted-by":"publisher","first-page":"836958","DOI":"10.3389\/fphar.2022.836958","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen L, Sun H, Zhao R, et al. Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1\/PD-L1) outcomes. Front Pharmacol. 2022;13:836958.","journal-title":"Front Pharmacol"},{"key":"1035_CR5","doi-asserted-by":"publisher","first-page":"102425","DOI":"10.1136\/jitc-2021-002349","volume":"9","author":"M Ahmed","year":"2021","unstructured":"Ahmed M, von Itzstein MS, Sheffield T, et al. Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors. J Immunother Cancer. 2021;9:102425.","journal-title":"J Immunother Cancer."},{"key":"1035_CR6","doi-asserted-by":"publisher","first-page":"103582","DOI":"10.1016\/j.critrevonc.2022.103582","volume":"170","author":"H Deng","year":"2022","unstructured":"Deng H, Zhao Y, Cai X, et al. PD-L1 expression and tumor mutation burden as pathological response biomarkers of neoadjuvant immunotherapy for early-stage non-small cell lung cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2022;170:103582.","journal-title":"Crit Rev Oncol Hematol."},{"key":"1035_CR7","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1001\/jamaoncol.2020.1046","volume":"6","author":"F Petrelli","year":"2020","unstructured":"Petrelli F, Ghidini M, Ghidini A, Tomasello G. Outcomes following immune checkpoint inhibitor treatment of patients with microsatellite instability-high cancers: a systematic review and meta-analysis. JAMA Oncol. 2020;6:1068\u201371.","journal-title":"JAMA Oncol"},{"key":"1035_CR8","first-page":"101134","volume":"41","author":"F Li","year":"2021","unstructured":"Li F, Li C, Cai X, et al. The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: a systematic review and meta-analysis. E Clin Med. 2021;41:101134.","journal-title":"E Clin Med."},{"key":"1035_CR9","doi-asserted-by":"publisher","first-page":"823087","DOI":"10.3389\/fnut.2022.823087","volume":"9","author":"L Ni","year":"2022","unstructured":"Ni L, Huang J, Ding J, et al. Prognostic nutritional index predicts response and prognosis in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Nut. 2022;9:823087.","journal-title":"Front Nut."},{"key":"1035_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","volume":"111","author":"S Diem","year":"2017","unstructured":"Diem S, Schmid S, Krapf M, et al. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017;111:176\u201381.","journal-title":"Lung Cancer"},{"key":"1035_CR11","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212\u201322.","journal-title":"Clin Cancer Res."},{"key":"1035_CR12","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","volume":"21","author":"S Kumagai","year":"2020","unstructured":"Kumagai S, Togashi Y, Kamada T, et al. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies. Nat Immunol. 2020;21:1346\u201358.","journal-title":"Nat Immunol."},{"key":"1035_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/0008-5472.CAN-20-1994","volume":"81","author":"CH Liu","year":"2021","unstructured":"Liu CH, Chen Z, Chen K, et al. Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy. Cancer Res. 2021;81:144\u201357.","journal-title":"Cancer Res."},{"key":"1035_CR14","doi-asserted-by":"publisher","first-page":"100118","DOI":"10.1016\/j.esmoop.2021.100118","volume":"6","author":"G Fornarini","year":"2021","unstructured":"Fornarini G, Rebuzzi SE, Banna GL, et al. Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort. ESMO Open. 2021;6:100118.","journal-title":"ESMO Open"},{"key":"1035_CR15","doi-asserted-by":"publisher","first-page":"589022","DOI":"10.3389\/fonc.2021.589022","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhang C, Peng Z, et al. Association of lymphocyte-to-monocyte ratio with survival in advanced gastric cancer patients treated with immune checkpoint inhibitor. Front Oncol. 2021;11:589022.","journal-title":"Front Oncol."},{"key":"1035_CR16","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s00262-021-02926-3","volume":"70","author":"WX Qi","year":"2021","unstructured":"Qi WX, Xiang Y, Zhao S, Chen J. Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab. Cancer Immunol Immunother. 2021;70:3199\u2013206.","journal-title":"Cancer Immunol Immunother"},{"key":"1035_CR17","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.","journal-title":"BMJ"},{"key":"1035_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"1035_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"1035_CR20","doi-asserted-by":"publisher","first-page":"899518","DOI":"10.3389\/fonc.2022.899518","volume":"12","author":"YT Wang","year":"2022","unstructured":"Wang YT, Kuo LT, Weng HH, et al. Systemic immun e-inflammation index as a predictor for head and neck cancer prognosis: a meta-analysis. Front Oncol. 2022;12:899518.","journal-title":"Front Oncol."},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12935-020-01308-6","volume":"20","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Sun Y, Zhang Q. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis. Cancer Cell Int. 2020;20:224.","journal-title":"Cancer Cell Int."},{"key":"1035_CR22","doi-asserted-by":"publisher","first-page":"814727","DOI":"10.3389\/fonc.2022.814727","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Dai M, Zhang Z. Prognostic significance of the systemic immune-inflammation index (SII) in patients with small cell lung cancer: a meta-analysis. Front Oncol. 2022;12:814727.","journal-title":"Front Oncol"},{"key":"1035_CR23","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.2147\/CMAR.S190006","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xiao G, Wang R. Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis. Cancer Manag Res. 2019;11:4185\u2013200.","journal-title":"Cancer Manag Res"},{"key":"1035_CR24","doi-asserted-by":"publisher","first-page":"537140","DOI":"10.3389\/fonc.2021.537140","volume":"11","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Zhang Z, Chen Y. Prognostic value of pretreatment systemic immune-inflammation index in gastric cancer: a meta-analysis. Front Oncol. 2021;11:537140.","journal-title":"Front Oncol"},{"key":"1035_CR25","doi-asserted-by":"publisher","first-page":"1758835","DOI":"10.1177\/1758835920937425","volume":"12","author":"M Dong","year":"2020","unstructured":"Dong M, Shi Y, Yang J, et al. Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis. Ther Adv Med Oncol. 2020;12:1758835.","journal-title":"Ther Adv Med Oncol"},{"key":"1035_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12957-022-02783-z","volume":"20","author":"B Zhang","year":"2022","unstructured":"Zhang B, Yao W. Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients. World J Surg Oncol. 2022;20:320.","journal-title":"World J Surg Oncol."},{"key":"1035_CR27","doi-asserted-by":"publisher","first-page":"20585","DOI":"10.18632\/aging.203449","volume":"13","author":"Y Shui","year":"2021","unstructured":"Shui Y, Li M, Su J, et al. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients. Aging (Albany NY). 2021;13:20585\u201397.","journal-title":"Aging (Albany NY)"},{"key":"1035_CR28","first-page":"12","volume":"1","author":"D Li","year":"2022","unstructured":"Li D, Zhao X, Pi X, Wang K, Song D. Systemic immune-inflammation index and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta-analysis. Clin Exp Med. 2022;1:12.","journal-title":"Clin Exp Med."},{"key":"1035_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12935-020-01590-4","volume":"20","author":"Y Huang","year":"2020","unstructured":"Huang Y, Gao Y, Wu Y, Lin H. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis. Cancer Cell Int. 2020;20:499.","journal-title":"Cancer Cell Int."},{"key":"1035_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ygyno.2020.10.011","volume":"160","author":"X Han","year":"2021","unstructured":"Han X, Liu S, Yang G, et al. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: a systemic review, meta-analysis, and meta-regression of observational studies. Gynecol Oncol. 2021;160:351\u201360.","journal-title":"Gynecol Oncol."},{"key":"1035_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","volume":"116","author":"RD Dolan","year":"2017","unstructured":"Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;116:134\u201346.","journal-title":"Crit Rev Oncol Hematol."},{"key":"1035_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4143\/crt.2020.330","volume":"53","author":"L Fang","year":"2021","unstructured":"Fang L, Yan FH, Liu C, et al. Systemic inflammatory biomarkers, especially fibrinogen to albumin ratio, predict prognosis in patients with pancreatic cancer. Cancer Res Treat. 2021;53:131\u20139.","journal-title":"Cancer Res Treat."},{"key":"1035_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","volume":"14","author":"S Xiong","year":"2021","unstructured":"Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14:173.","journal-title":"J Hematol Oncol."},{"key":"1035_CR34","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3390\/cancers13215333","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang Y, Onuma A, et al. Neutrophils extracellular traps inhibition improves PD-1 blockade immunotherapy in colorectal cancer. Cancers (Basel). 2021;13:1024.","journal-title":"Cancers (Basel)."},{"key":"1035_CR35","first-page":"1295","volume":"59","author":"B Nieswandt","year":"1999","unstructured":"Nieswandt B, Hafner M, Echtenacher B, M\u00e4nnel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59:1295\u2013300.","journal-title":"Cancer Res"},{"key":"1035_CR36","doi-asserted-by":"publisher","first-page":"640578","DOI":"10.3389\/fimmu.2021.640578","volume":"12","author":"L Schmied","year":"2021","unstructured":"Schmied L, H\u00f6glund P, Meinke S. Platelet-mediated protection of cancer cells from immune surveillance-possible implications for cancer immunotherapy. Front Immunol. 2021;12:640578.","journal-title":"Front Immunol"},{"key":"1035_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123\u201334.","journal-title":"Nat Rev Cancer"},{"key":"1035_CR38","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234:8509\u201321.","journal-title":"J Cell Physiol."},{"key":"1035_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1078155220913106","volume":"27","author":"S Yucel","year":"2021","unstructured":"Yucel S, Bilgin B. The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer. J Oncol Pharm Pract. 2021;27:71\u20137.","journal-title":"J Oncol Pharm Pract."},{"key":"1035_CR40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11523-018-0574-1","volume":"13","author":"A Farolfi","year":"2018","unstructured":"Farolfi A, Petrone M, Scarpi E, et al. Inflammatory indexes as prognostic and predictive factors in ovarian cancer treated with chemotherapy alone or together with bevacizumab. A multicenter, retrospective analysis by the MITO Group (MITO 24). Target Oncol. 2018;13:469\u201379.","journal-title":"Target Oncol."}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01035-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01035-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01035-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:07:24Z","timestamp":1698782844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01035-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,26]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01035-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,26]]},"assertion":[{"value":"27 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a meta-analysis. The Hangzhou Cancer Hospital Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}